Christopher Emig

Christopher Emig is a prominent figure in the biotech industry with extensive experience in computational biology, bioinformatics, and laboratory automation.12 He currently serves as the Co-Founder and CEO of Augmenta Bioworks, a company he founded in 2016 and is based in Menlo Park, California.1

Professional Experience

Emig has been a Scientific Advisor at Chimera Bio since May 2016.1 In addition to his role at Chimera Bio, he has held several other notable positions:

• Co-Founder and CEO of Augmenta Bioworks (2016 - Present)
• Scientific Advisor at Gen9, Inc. (2009 - 2017)
• Graduate Research Assistant at Stanford University (2009 - 2015)
• Consultant in computational biology and bioinformatics (2009 - 2014)
• Project Manager and Process Engineer at Codon Devices (2006 - 2009)
• Research Assistant at Massachusetts Institute of Technology (2004 - 2006)

Education

Christopher Emig has a strong educational background in biology and engineering:

• Ph.D. in Bioengineering from Stanford University (2009 - 2015)
• M.Eng. in Electrical Engineering and Computer Science from MIT (2004 - 2005)
• Dual BS in Biology and Electrical Engineering and Computer Science from MIT (2000 - 2004)

Current Focus

As the CEO of Augmenta Bioworks, Emig is actively involved in discovering new therapeutics by harnessing natural human immunity.3 His company has shown promising results, with successful targeted discoveries and a partnership with TFF Therapeutics.3

Christopher Emig's diverse experience and expertise in computational biology, bioinformatics, and laboratory automation have positioned him as a valuable advisor and leader in the biotech industry.2